Compile Data Set for Download or QSAR
maximum 50k data
Found 468 of ic50 for UniProtKB: P30419
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50520331(CHEMBL4445137)
Affinity DataIC50: <1nMAssay Description:Inhibition of human N-myristoyltransferase assessed as reduction in CoASH production by fluorogenic detection based assayMore data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50520331(CHEMBL4445137)
Affinity DataIC50: <1nMAssay Description:Inhibition of human NMT1 by fluorescence methodMore data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185107(US9156811, DDD100868)
Affinity DataIC50:  2nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184848(US9156811, DDD85646)
Affinity DataIC50:  3nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184902(US9156811, DDD86481)
Affinity DataIC50:  3nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184977(US9156811, DDD88646)
Affinity DataIC50:  3nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50364113(CHEMBL1230468)
Affinity DataIC50:  3nMAssay Description:Inhibition of human N-myristoyltransferase 1 using [3H]myristoyl-CoA and GCGGSKVKPQPPQAK(biotin)-amide as substrate preincubated for 5 mins prior sub...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50364113(CHEMBL1230468)
Affinity DataIC50:  3nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184854(US9156811, DDD86206)
Affinity DataIC50:  3nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033616(CHEMBL3358119)
Affinity DataIC50:  4nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033485(CHEMBL3357702)
Affinity DataIC50:  4nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033480(CHEMBL3357697)
Affinity DataIC50:  4nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033418(CHEMBL3357685)
Affinity DataIC50:  4nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185101(US9156811, DDD100807)
Affinity DataIC50:  4nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185092(US9156811, DDD100798)
Affinity DataIC50:  4nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184978(US9156811, DDD90022)
Affinity DataIC50:  4nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50364113(CHEMBL1230468)
Affinity DataIC50:  4nMAssay Description:Inhibition of human NMT1 using [3H]-myristoyl-coA/biotinylated CAP5.5 as substrate after 15 mins by scintillation/luminescence counting methodMore data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033618(CHEMBL3358121)
Affinity DataIC50:  5nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033617(CHEMBL3358120)
Affinity DataIC50:  5nMAssay Description:Inhibition of human NMT1 using [3H]-myristoyl-coA/biotinylated CAP5.5 as substrate after 15 mins by scintillation/luminescence counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185083(US9156811, DDD100169)
Affinity DataIC50:  5nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033482(CHEMBL3357699)
Affinity DataIC50:  5nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033617(CHEMBL3358120)
Affinity DataIC50:  5nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184943(US9156811, DDD88193)
Affinity DataIC50:  5nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184988(US9156811, DDD90107)
Affinity DataIC50:  5nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184992(US9156811, DDD90118)
Affinity DataIC50:  5nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185061(US9156811, DDD100144)
Affinity DataIC50:  6nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184937(US9156811, DDD88186)
Affinity DataIC50:  6nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185108(US9156811, DDD100869)
Affinity DataIC50:  6nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50364135(CHEMBL1951295)
Affinity DataIC50:  7nMAssay Description:Inhibition of human N-myristoyltransferase 1 using [3H]myristoyl-CoA and GCGGSKVKPQPPQAK(biotin)-amide as substrate preincubated for 5 mins prior sub...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184965(US9156811, DDD88558)
Affinity DataIC50:  7nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184860(US9156811, DDD86213)
Affinity DataIC50:  7nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185078(US9156811, DDD100164)
Affinity DataIC50:  7nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033619(CHEMBL3358122)
Affinity DataIC50:  8nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185080(US9156811, DDD100166)
Affinity DataIC50:  8nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033478(CHEMBL3357695)
Affinity DataIC50:  8nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185023(US9156811, DDD99759)
Affinity DataIC50:  8nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184903(US9156811, DDD87748)
Affinity DataIC50:  8nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184920(US9156811, DDD87767)
Affinity DataIC50:  8nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184859(US9156811, DDD86212)
Affinity DataIC50:  8nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185054(US9156811, DDD100096)
Affinity DataIC50:  9nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033414(CHEMBL3357681)
Affinity DataIC50:  9nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033487(CHEMBL3357704)
Affinity DataIC50:  9nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185050(US9156811, DDD100091)
Affinity DataIC50:  9nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184923(US9156811, DDD87993)
Affinity DataIC50:  9nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184939(US9156811, DDD88188)
Affinity DataIC50:  9nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184985(US9156811, DDD90091)
Affinity DataIC50:  9nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033614(CHEMBL3358117)
Affinity DataIC50:  9nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50250777(CHEMBL4080376)
Affinity DataIC50:  10nMAssay Description:Inhibition of human NMT1 using [3H]-myristoyl-coA/biotinylated CAP5.5 as substrate after 15 mins by scintillation/luminescence counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185060(US9156811, DDD100143)
Affinity DataIC50:  10nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184984(US9156811, DDD90086)
Affinity DataIC50:  10nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 468 total ) | Next | Last >>
Jump to: